Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION (Details)

v3.10.0.1
SEGMENT INFORMATION (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Revenues $ 413,503 $ 317,450 $ 1,217,509 $ 758,487  
Depreciation 135,628 24,322 383,603 58,478  
Interest expenses 25,205 52,932 287,123 94,932  
Net income (loss) (2,403,251) (710,729) (5,298,035) (1,690,570)  
Identifiable long-lived tangible assets 8,192,438   8,192,438   $ 7,671,786
Real property operating [Member]          
Revenues 272,444 315,284 847,939 537,538  
Depreciation 32,624 20,568 97,873 53,511  
Interest expenses 25,205 52,932 287,123 94,932  
Net income (loss) 542 (119,782) (231,541) (121,016)  
Identifiable long-lived tangible assets 7,940,069   7,940,069   7,645,371
Medical related consulting services [Member]          
Revenues 71,398 2,166 213,394 220,949  
Depreciation 4,706 3,754 12,703 4,967  
Interest expenses  
Net income (loss) (75,484) (116,230) (232,502) (278,019)  
Identifiable long-lived tangible assets 8,640   8,640   20,558
Development services and sales of developed products[Member]          
Revenues 69,661 156,176  
Depreciation 98,298 273,027  
Interest expenses  
Net income (loss) (146,451) (443,479)  
Identifiable long-lived tangible assets 243,729   243,729   $ 5,857
Others [Member]          
Net income (loss) [1] $ (2,181,858) $ (474,717) $ (4,390,513) $ (1,291,535)  
[1] The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.